1. Home
  2. Analysis

Neutrophil count increased and drugs of ingredients of lisdexamfetamine dimesylate (a real world drug study)


Summary:

Neutrophil count increased is found among people who take drugs with ingredients of lisdexamfetamine dimesylate, especially for people who are male, 30-39 old , have been taking the drugs for 1 - 6 months. This phase IV clinical study is created by eHealthMe based on reports of 31,213 people who have side effects when taking drugs with ingredients of lisdexamfetamine dimesylate from the FDA, and is updated regularly.

Drug(s) considered in the study (i.e. both brand name and generic drugs): Lisdexamfetamine dimesylate, Vyvanse.

eHealthMe: drug outcomes in the real world

eHealthMe runs one of the largest post-marketing drug safety studies in the world. We study millions of patients and 5,000 more each day. Our data-driven phase IV clinical trials have been referenced on 800+ peer-reviewed medical publications including The Lancet, Mayo Clinic Proceedings, and Nature. Tools to study our phase IV findings are available to the public, anonymous and free >>>.

On Aug, 20, 2026

31,213 people reported to have side effects when taking drugs with ingredients of lisdexamfetamine dimesylate.
Among them, 26 people (0.08%) have Neutrophil count increased

What is Neutrophil count increased?

Neutrophil count increased (excess than normal number of neutrophil a type of blood cell) is found to be associated with 943 drugs and 1,170 conditions by eHealthMe. Check the latest studies of Neutrophil count increased.

Number of reports submitted per year:

Could drugs with ingredients of lisdexamfetamine dimesylate cause Neutrophil count increased?

Time on drugs with ingredients of lisdexamfetamine dimesylate when people have Neutrophil count increased *:

  • < 1 month: 0.0 %
  • 1 - 6 months: 100 %
  • 6 - 12 months: 0.0 %
  • 1 - 2 years: 0.0 %
  • 2 - 5 years: 0.0 %
  • 5 - 10 years: 0.0 %
  • 10+ years: 0.0 %

Gender of people who have Neutrophil count increased when taking drugs with ingredients of lisdexamfetamine dimesylate *:

  • female: 44 %
  • male: 56 %

Age of people who have Neutrophil count increased when taking drugs with ingredients of lisdexamfetamine dimesylate *:

  • 0-1: 0.0 %
  • 2-9: 0.0 %
  • 10-19: 5.5600000000000005 %
  • 20-29: 11.11 %
  • 30-39: 61.11 %
  • 40-49: 16.67 %
  • 50-59: 0.0 %
  • 60+: 5.5600000000000005 %

Conditions people have *:

You may use this to check any potential undetected conditions.

  1. Pain: 11 people, 42.31%
  2. Insomnia (sleeplessness): 9 people, 34.62%
  3. Bipolar Disorder (mood disorder): 7 people, 26.92%
  4. Schizophrenia (a mental disorder characterized by a breakdown of thought processes): 7 people, 26.92%
  5. Relapsing-Remitting Multiple Sclerosis (reoccurrence of an inflammatory disease in which the insulating covers of nerve cells in the brain and spinal cord are damaged): 6 people, 23.08%
  6. Fatigue (feeling of tiredness): 6 people, 23.08%
  7. Sleep Disorder: 6 people, 23.08%
  8. Stress And Anxiety: 4 people, 15.38%
  9. Mood Swings (an extreme or rapid change in mood): 4 people, 15.38%
  10. Chest Pain: 3 people, 11.54%

Other drugs people take *:

You may use this to check any potential interacting drugs.

  1. Benadryl: 10 people, 38.46%
  2. Clozaril: 8 people, 30.77%
  3. Seroquel: 8 people, 30.77%
  4. Omacor: 7 people, 26.92%
  5. Wellbutrin: 7 people, 26.92%
  6. Sertraline: 6 people, 23.08%
  7. Zopiclone: 6 people, 23.08%
  8. Gravol: 6 people, 23.08%
  9. Risperdal: 5 people, 19.23%
  10. Abilify: 5 people, 19.23%

Other side effects people have besides Neutrophil count increased *:

You may use this to check any potential undetected side effects.

  1. White Blood Cell Count Increased: 15 people, 57.69%
  2. Lymphocyte Count Decreased: 12 people, 46.15%
  3. Haemoglobin Decreased: 10 people, 38.46%
  4. Haematocrit Decreased: 10 people, 38.46%
  5. Alanine Aminotransferase Increased: 10 people, 38.46%
  6. Eosinophil Count Increased: 10 people, 38.46%
  7. Aspartate Aminotransferase Increased: 10 people, 38.46%
  8. Head Injury: 9 people, 34.62%
  9. Thrombocytopenia (decrease of platelets in blood): 9 people, 34.62%
  10. C-Reactive Protein Increased: 8 people, 30.77%

* Approximation only. Some reports may have incomplete information.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Related publications that referenced our studies

Related studies

Drugs with ingredients of lisdexamfetamine dimesylate, their effectiveness, alternatives and more:

How the study uses the data?

The study uses data from the FDA. It is based on lisdexamfetamine dimesylate. All drugs that have the same active ingredients (e.g. brand name and generic drugs) are considered. Dosage of drugs is not considered in the study.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.

Recent studies on eHealthMe:

© 2026 eHealthMe.com. All rights reserved. Use of this site constitutes acceptance of eHealthMe.com's terms of service and privacy policy.